ESLT vs. TRVI
ESLT (Elbit Systems Ltd) and TRVI (Trevi Therapeutics, Inc.) are both stocks. ESLT operates in Aerospace & Defense (Industrials), while TRVI operates in Biotechnology (Healthcare). Over the past 5 years, ESLT returned 46.38%/yr vs 44.83%/yr for TRVI. At a 0.10 correlation, their price movements are largely independent.
Performance
ESLT vs. TRVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESLT achieves a 48.00% return, which is significantly higher than TRVI's 13.50% return.
ESLT
- 1D
- -6.48%
- 1M
- 9.58%
- YTD
- 48.00%
- 6M
- 66.16%
- 1Y
- 98.98%
- 3Y*
- 60.86%
- 5Y*
- 46.38%
- 10Y*
- 26.53%
TRVI
- 1D
- 5.57%
- 1M
- -6.94%
- YTD
- 13.50%
- 6M
- 11.28%
- 1Y
- 130.31%
- 3Y*
- 75.70%
- 5Y*
- 44.83%
- 10Y*
- —
ESLT vs. TRVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ESLT Elbit Systems Ltd | 48.00% | 125.14% | 22.17% | 31.30% | -4.82% | 34.77% | -14.56% | 13.63% |
TRVI Trevi Therapeutics, Inc. | 13.50% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
Correlation
The correlation between ESLT and TRVI is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.10 |
Fundamentals
ESLT:
$12.36
TRVI:
-$0.43
ESLT:
$8.23B
TRVI:
$0.00
ESLT:
$2.03B
TRVI:
-$31.00K
ESLT:
$861.06M
TRVI:
-$49.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESLT vs. TRVI — Risk / Return Rank
ESLT
TRVI
ESLT vs. TRVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Elbit Systems Ltd (ESLT) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESLT | TRVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.47 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.35 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 3.83 | 4.44 | -0.61 |
| Martin ratioReturn relative to average drawdown | 10.61 | 10.40 | +0.21 |
Loading charts...
Drawdowns
ESLT vs. TRVI - Drawdown Comparison
The maximum ESLT drawdown since its inception was -53.79%, smaller than the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for ESLT and TRVI.
Loading charts...
Drawdown Indicators
| ESLT | TRVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.79% | -95.45% | +41.66% |
Max Drawdown (1Y)Largest decline over 1 year | -25.98% | -29.50% | +3.52% |
Max Drawdown (3Y)Largest decline over 3 years | -25.98% | -61.96% | +35.98% |
Max Drawdown (5Y)Largest decline over 5 years | -32.89% | -80.26% | +47.37% |
Max Drawdown (10Y)Largest decline over 10 years | -32.89% | — | — |
Current DrawdownCurrent decline from peak | -15.71% | -7.73% | -7.98% |
Average DrawdownAverage peak-to-trough decline | -13.91% | -61.49% | +47.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.36% | 12.58% | -3.22% |
Volatility
ESLT vs. TRVI - Volatility Comparison
Elbit Systems Ltd (ESLT) has a higher volatility of 19.89% compared to Trevi Therapeutics, Inc. (TRVI) at 13.78%. This indicates that ESLT's price experiences larger fluctuations and is considered to be riskier than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESLT | TRVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.89% | 13.78% | +6.11% |
Volatility (6M)Calculated over the trailing 6-month period | 35.93% | 39.38% | -3.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.11% | 60.39% | -16.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.66% | 88.26% | -54.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.42% | 99.35% | -69.93% |
Dividends
ESLT vs. TRVI - Dividend Comparison
ESLT's dividend yield for the trailing twelve months is around 0.36%, while TRVI has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ESLT Elbit Systems Ltd | 0.36% | 0.47% | 0.77% | 0.94% | 1.22% | 1.03% | 1.28% | 1.14% | 1.54% | 1.32% | 1.57% | 1.63% |
TRVI Trevi Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ESLT vs. TRVI - Financials Comparison
This section allows you to compare key financial metrics between Elbit Systems Ltd and Trevi Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ESLT and TRVI have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ESLT has higher volatility (19.89%) compared to TRVI (13.78%). In terms of maximum drawdown, ESLT dropped -53.79% vs TRVI's -95.45%.
ESLT currently has the higher Sharpe Ratio (2.26 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESLT and TRVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer